The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Cellular Therapies - T Cells - Axicabtagene ciloleucel, cryopreserved - T - Yescarta - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (400895)
ARTG Name
Cellular Therapies - T Cells - Axicabtagene ciloleucel, cryopreserved - T - Yescarta - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag
Product name
T Cells - Axicabtagene ciloleucel, cryopreserved - T - Yescarta
ARTG Date
Registration Type
Biological
Therapeutic good type
Biological
Sponsor
Ingredients
axicabtagene ciloleucel
Licence category
INC
Licence status
A
Licence class
Class 4
Summary
Product Information
Consumer Medicine Information